NSCLC Stage IV Clinical Trials
0 recruiting
Showing 1–20 of 22 trials
Recruiting
Phase 2
Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC
NSCLC Stage IV
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer30 enrolled20 locationsNCT06552234
Recruiting
Phase 2
Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC
NSCLC Stage IV
European Organisation for Research and Treatment of Cancer - EORTC136 enrolled16 locationsNCT06219317
Recruiting
Phase 1Phase 2
Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC
NSCLC Stage IVNSCLC, Recurrent
University of Kansas Medical Center25 enrolled2 locationsNCT04467723
Recruiting
TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%
NSCLC Stage IVPD-L1 Gene MutationAtezolizumab+1 more
Antalya Training and Research Hospital150 enrolled19 locationsNCT07279402
Recruiting
Phase 3
ResQ201A: Clinical Trial Of N-803 Plus TISLELIZUMAB And DOCETAXEL Versus DOCETAXEL Monotherapy In Participants With Advanced Or Metastatic Non-Small Cell Lung Cancer
NSCLC Stage IV
ImmunityBio, Inc.460 enrolled9 locationsNCT06745908
Recruiting
Phase 1Phase 2
Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC
NSCLC Stage IVALK Fusion Protein Expression
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins12 enrolled1 locationNCT05950139
Recruiting
Phase 2
Pemetrexed and Carboplatin With or Without Anlotinib Hydrochloride for Osimertinib-resistant Non-squamous NSCLC
NSCLC Stage IV
Fudan University105 enrolled1 locationNCT04136535
Recruiting
Phase 1Phase 2
A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC
NSCLC Stage IVMalignant Pleural Effusions
Wuhan YZY Biopharma Co., Ltd.96 enrolled1 locationNCT05543330
Recruiting
Not Applicable
Outpatient Pulmonary Rehabilitation in Non-small-cell Lung Cancer Receiving Immunotherapy
NSCLC Stage IV
Karl Landsteiner Institute for Lung Research and Pneumological Oncology70 enrolled1 locationNCT06436625
Recruiting
Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations
NSCLCNSCLC Stage IVNSCLC, Recurrent
Shanghai Chest Hospital500 enrolled2 locationsNCT05701787
Recruiting
Phase 2
Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases
Brain Metastases, AdultNSCLC Stage IV
Maastricht University Medical Center25 enrolled3 locationsNCT06401824
Recruiting
Phase 2
SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors
NSCLC Stage IV
Fudan University59 enrolled1 locationNCT04767009
Recruiting
Lung Cancer Registry
Lung CancerNSCLC Stage IV
Arbeitsgemeinschaft medikamentoese Tumortherapie500 enrolled3 locationsNCT04654364
Recruiting
Phase 2
Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG)
NSCLC Stage IVNSCLC Stage IIIB
Goethe University50 enrolled16 locationsNCT05281406
Recruiting
AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer
NSCLC Stage IV
IRCCS San Raffaele2,000 enrolled1 locationNCT06788366
Recruiting
Phase 2
Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain Metastasis
Brain MetastasesNSCLC Stage IV
Fudan University54 enrolled1 locationNCT06501391
Recruiting
Phase 2
Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Active Brain Metastasis
NSCLC Stage IV
Fudan University40 enrolled1 locationNCT06501378
Recruiting
ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer
NSCLC Stage IVSex DisorderHypogonadism, Male+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS80 enrolled1 locationNCT06532149
Recruiting
Longitudinal Assessment of Genomic Alterations and Clonal Evolution in ALK-positive NSCLC (Galileo Project)
NSCLC Stage IVALK Gene MutationALK Sensitizing Mutation
Fondazione Policlinico Universitario Agostino Gemelli IRCCS108 enrolled1 locationNCT06234579
Recruiting
Phase 2
Treatment Response Adapted Hybrid Radiotherapy in Metastatic Non-small Cell Lung Cancer Receiving First-line Immunotherapy
NSCLC Stage IV
Fudan University146 enrolled1 locationNCT06313541